Table 1. HI antibody titers were detected at 2, 4, 6 and 8 wpv.
HI | |||||
---|---|---|---|---|---|
2 wpv | 4 wpv. | 6 wpv | 8 wpv | ||
Group 1 | pVAX1-HA | 8 | 25.40 | 32a,b | 12.70 |
Group 2 | rCAV2-HA | 32 | 41.78 | 98.05a,c | 25.40 |
Group 3 | Inactivated vaccine | 32 | 47.95 | 120.82b,c | 40.32 |
Group 4 | pVAX1 | < 2 | < 2 | < 2 | < 2 |
Group 5 | CAV2 | < 2 | < 2 | < 2 | < 2 |
Group 6 | Adjuvant | < 2 | < 2 | < 2 | < 2 |
Group 7 | PBS | < 2 | < 2 | < 2 | < 2 |
Group 8 | NI | < 2 | < 2 | < 2 | < 2 |
Notes:
Data are presented as geometric mean titer (n = 12, at 2, 4 and 6 wpv; n = 3, at 8 wpv).
Significant or extremely significant difference at p < 0.05 or p < 0.01, respectively.
NI = No immunization
CAV2-HA = live recombinant canine adenovirus 2 (CAV2) vector expressing the H3 hemagglutinin protein from the virus strain A/canine/Guangdong/01/2006(H3N2).
CAV2 = empty CAV2 vector
wpv = weeks post-vaccination
a,b,c The same letter indicates the intergroup difference analysis.
aThe difference is extremely significant (p < 0.01); bThe difference is extremely significant (p < 0.01); cThe difference is not significant (p > 0.05).